[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ovary-injury\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ovary-injury":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100536194","improving-the-quality-of-cryopreserved-ovarian-tissue-reimplantation-using-platelet-enriched-autologous-plasma-100536194",false,"NCT06261658","Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma","TESOVA2022","Inclusion Criteria:\n\n* request for cryopreserved ovarian tissue transplantation;\n* premature ovarian failure or irregular mentrual cycles;\n* negative test for HIV, HBV, HCV, Treponema pallidum;\n* negative PAP test;\n* oncological authorization;\n* absence of neoplastic contamination in the cryopreserved ovarian tissue;\n* Informed consent\n\nExclusion Criteria:\n\n* neoplastic contamination in cryopreserved ovarian tissue;\n* history of endometriosis;\n* endocrinological disorders present and not treated (uncompensated thyroid dysfunction, diabetes (type 1, type 2);\n* body mass index (BMI) \\>30 kg\u002Fm2;\n* circulating platelet level \\\u003C 150,000 \u002F mml;\n* bacterial infection;\n* ongoing use of anticoagulants;\n* bleeding diathesis.","FEMALE",{"count":18,"type":19},45,"ESTIMATED","INTERVENTIONAL",[22],"NA","The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.",[25,26,27,28],"Cryopreservation","Ovary Injury","Infertility, Female","Menopause Ovarian Failure",[30,31,32,33,34],"Cryopreserved Ovarian Tissue","Ovarian tissue transplantation","Platelet-enriched Autologous Plasma","ovarian endocrine function","livebirths","RECRUITING","2024-02-08",{"date":38,"type":39},"2024-02-15","ACTUAL",{"date":41,"type":19},"2024-03-01",{"date":43,"type":19},"2033-12-29",{"name":45,"class":46},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER"]